Key Points
- CEO Stephen Beard sold 3,639 Adtalem shares for approximately $474,416 at an average price of $130.37 under a pre-arranged Rule 10b5-1 trading plan. He retains 473,825 shares valued at roughly $61.8 million.
- Adtalem reported quarterly EPS of $2.09, beating the $1.90 analyst consensus, on revenue of $501.38 million. The company’s FY2027 EPS guidance is $8.90–$9.15.
- Analyst sentiment remains mixed, with an overall “Hold” rating and a consensus price target of $151.67; institutional investors own 98.84% of the stock.
Adtalem Global Education Inc. (NYSE:CVSA - Get Free Report) CEO Stephen Beard sold 3,639 shares of the stock in a transaction that occurred on Thursday, October 8th. The shares were sold at an average price of $130.37, for a total transaction of $474,416.43. Following the transaction, the chief executive officer owned 473,825 shares in the company, valued at $61,772,565.25. The trade was a 0.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Adtalem Global Education Trading Down 0.8%
CVSA stock opened at $129.27 on Friday. The company has a market capitalization of $4.38 billion, a PE ratio of 18.36, a price-to-earnings-growth ratio of 0.97 and a beta of 0.65. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.09. Adtalem Global Education Inc. has a one year low of $86.97 and a one year high of $156.26. The company's 50 day moving average price is $128.45 and its two-hundred day moving average price is $123.73.
Adtalem Global Education (NYSE:CVSA - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $2.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.90 by $0.19. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. The company had revenue of $501.38 million during the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, analysts predict that Adtalem Global Education Inc. will post 9.00 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on the company. Truist Financial lowered Adtalem Global Education from a "buy" rating to a "hold" rating and set a $140.00 target price for the company. in a research note on Thursday, September 3rd. BMO Capital Markets decreased their price target on Adtalem Global Education from $148.00 to $145.00 and set an "outperform" rating on the stock in a research note on Monday, October 5th. Wall Street Zen upgraded Adtalem Global Education from a "hold" rating to a "buy" rating in a research report on Sunday, September 27th. Finally, Weiss Ratings lowered Adtalem Global Education from a "hold (c+)" rating to a "hold (c)" rating in a research note on Tuesday. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Adtalem Global Education has an average rating of "Hold" and a consensus price target of $151.67.
Check Out Our Latest Stock Analysis on CVSA
Hedge Funds Weigh In On Adtalem Global Education
An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management bought a new position in shares of Adtalem Global Education Inc. (NYSE:CVSA - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 11,622 shares of the company's stock, valued at approximately $1,449,000. Institutional investors own 98.84% of the company's stock.
About Adtalem Global Education
(
Get Free Report)
Adtalem Global Education is an education services company that provides professional, postsecondary and healthcare-focused education through institutions and brands serving students and working professionals. Its offerings include degree programs, career training, certification preparation and continuing education.
The company's academic institutions include Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, Ross University School of Veterinary Medicine and the Medical University of the Americas.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
